Functional characterization of several LQTS-associated calmodulin (CaM) pathogenic variants has shown that they mostly affect its Ca+2-binding affinity, consequently impairing the Ca2-dependent inactivation (CDI) of the L-type Ca+2 channel (CaV1.2). The gene discussed is CALM3; the disease is familial long QT syndrome.